LFCM

Long Focus Capital Management Portfolio holdings

AUM $1.55B
This Quarter Return
-1.88%
1 Year Return
+20.57%
3 Year Return
+43.45%
5 Year Return
10 Year Return
AUM
$367M
AUM Growth
Cap. Flow
+$367M
Cap. Flow %
100%
Top 10 Hldgs %
42.32%
Holding
98
New
95
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

1 Financials 24.63%
2 Energy 21.39%
3 Healthcare 15.96%
4 Communication Services 9.96%
5 Industrials 8.79%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
LCTX icon
76
Lineage Cell Therapeutics
LCTX
$267M
$527K 0.07% +215,000 New +$527K
NBR icon
77
Nabors Industries
NBR
$543M
$527K 0.07% +6,500 New +$527K
MBI icon
78
MBIA
MBI
$402M
$474K 0.06% +30,000 New +$474K
ACHV icon
79
Achieve Life Sciences
ACHV
$152M
$467K 0.06% +60,000 New +$467K
TE
80
T1 Energy Inc.
TE
$257M
$447K 0.06% +40,000 New +$447K
BOXL icon
81
Boxlight
BOXL
$4.76M
$414K 0.05% +300,000 New +$414K
CRKN
82
DELISTED
Crown Electrokinetics Corp. Common Stock
CRKN
$356K 0.05% +89,259 New +$356K
DISH
83
DELISTED
DISH Network Corp.
DISH
$324K 0.04% +10,000 New +$324K
TLYS icon
84
Tilly's
TLYS
$59.4M
$322K 0.04% +20,000 New +$322K
CDXS icon
85
Codexis
CDXS
$246M
$313K 0.04% +10,000 New +$313K
PRA icon
86
ProAssurance
PRA
$1.22B
$253K 0.03% +10,000 New +$253K
TUSK icon
87
Mammoth Energy Services
TUSK
$114M
$223K 0.03% +122,681 New +$223K
ATER icon
88
Aterian
ATER
$9.65M
$206K 0.03% +50,000 New +$206K
IGICW
89
DELISTED
International General Insurance Holdings Ltd. Warrants expiring 03/17/2025
IGICW
$171K 0.02% +220,005 New +$171K
AMBC icon
90
Ambac
AMBC
$419M
$161K 0.02% +10,000 New +$161K
BIVI icon
91
BioVie
BIVI
$11.5M
$90K 0.01% +20,000 New +$90K
MBII
92
DELISTED
Marrone Bio Innovations, Inc.
MBII
$72K 0.01% +100,000 New +$72K
ONCS
93
DELISTED
OncoSec Medical Incorporated
ONCS
$66K 0.01% +69,226 New +$66K
ANIX icon
94
Anixa Biosciences
ANIX
$96.3M
$63K 0.01% +21,297 New +$63K
ONCY
95
Oncolytics Biotech
ONCY
$105M
$56K 0.01% +40,000 New +$56K
ABBV icon
96
AbbVie
ABBV
$372B
0
BMY icon
97
Bristol-Myers Squibb
BMY
$96B
0
CVX icon
98
Chevron
CVX
$324B
0